A*STAR Skin Research Labs (A*STAR SRL)

New insights into the age-associated changes affecting macrophages offer promising avenues for the treatment of chronic wounds.

A new 3D-printed microneedle array could prove a more effective, less invasive diagnostic tool to extract disease-causing fungi from deep skin layers.

Scientists discover how a gene expressed in hair follicle cells controls hair pigmentation, creating new opportunities for future skin cancer therapeutics.

Electrospun scaffolds mirror the structural architecture of the skin’s dermis, creating a foundation to promote healing in chronic wounds.

As Sir David and Birgit Lane leave Singapore, A*STAR Research commemorates the legacy that the couple continues to build for their students, colleagues and the nation’s wider research ecosystem.

Leveraging on its public sector and industry collaborations, A*STAR and the Experimental Drug Development Centre hold the keys to effective drug discovery and development.

By analysing heart cells, a new machine learning algorithm could help predict arrhythmia risk before symptoms appear.

More evidence emerges that fatty foods change skin composition, creating the perfect conditions for acne flare-ups.

Fine-tuning the levels of three skin cell metabolites could be the key to unlocking treatments for psoriasis and ageing skin.

The identification of a class of inflammatory immune cells offers new opportunities to treat chronic skin conditions.

Researchers discover that the deletion of a gene linked to glucose metabolism leads to smaller pancreatic tumours and better patient survival.

Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.